PRTAPROTHENA CORP PUBLIC LTD COvs its industry peers
A metric-by-metric comparison of PROTHENA CORP PUBLIC LTD CO against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRTAThis | $429M#8 | — | 1.5x#3 | 44.3x#6 | -92.8%#7 | -99.6%#10 | -2216.4%#6 | -85.1%#10 | — | — | 2.2%#7 | — |
| MPLT | $513M#1 | 0.3x#1 | 1.5x#2 | — | — | -107.7%#12 | — | -46.3%#7 | — | — | — | — |
| CAPR | $498M#2 | — | 2.0x#4 | — | -100.0%#8 | -159.6%#14 | — | -42.7%#6 | — | — | 41.9%#6 | — |
| IRD | $483M#3 | — | — | 34.0x#5 | 29.1%#2 | 13.8%#2 | -271.9%#5 | — | — | — | 326.8%#1 | — |
| INDP | $482M#4 | — | 42.4x#13 | — | — | -38.8%#7 | — | -183.3%#12 | — | — | 57.4%#5 | — |
| PBYI | $478M#5 | 18.2x#3 | 3.5x#11 | 2.1x#2 | -0.9%#3 | 2.8%#4 | 16.3%#1 | 22.5%#1 | — | — | 99.8%#3 | — |
| RLMD | $475M#6 | — | 2.3x#7 | 92548.4x#7 | -35.4%#5 | — | -1152275.3%#7 | 0.0%#2 | — | — | 164.9%#2 | — |
| ARCT | $450M#7 | — | 2.6x#8 | 5.5x#4 | -46.1%#6 | 18.7%#1 | -93.0%#3 | -38.3%#4 | -136.2%#2 | — | -12.7%#9 | — |
| SPRY | $421M#9 | — | 33.7x#12 | 5.0x#3 | -5.5%#4 | -2241.8%#15 | -212.9%#4 | -1369.1%#15 | -177.6%#3 | — | -57.5%#14 | — |
| AVIR | $419M#10 | — | 2.1x#5 | 1.2x#1 | 622.5%#1 | 6.0%#3 | -51.5%#2 | -77.4%#9 | — | — | 72.3%#4 | — |
| GTBP | $410M#11 | 1.7x#2 | 114.8x#14 | — | — | -115.4%#13 | — | -794.5%#14 | — | — | -54.8%#13 | 0.1%#1 |
| LRMR | $408M#12 | — | 3.2x#9 | — | — | -105.5%#11 | — | -130.1%#11 | -350.3%#4 | — | -1.0%#8 | — |
| RZLT | $402M#13 | — | 3.4x#10 | — | — | -8.7%#5 | — | -63.7%#8 | -72.2%#1 | — | -44.1%#11 | — |
| TTRX | $395M#14 | — | 575.0x#15 | — | — | -80.6%#9 | — | -465.0%#13 | — | — | — | — |
| BBOT | $391M#15 | — | 1.2x#1 | — | — | -80.5%#8 | — | -41.5%#5 | — | — | -50.4%#12 | — |
| BNTC | $389M#16 | — | 2.2x#6 | — | -100.0%#8 | -20.1%#6 | — | -25.7%#3 | — | — | -17.9%#10 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice